VRS
PTGX icon

Virginia Retirement Systems’s Protagonist Therapeutics PTGX Stock Holding History

Virginia Retirement Systems’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.22M Buy
25,400
+9,800
+63% +$802K 0.01% 400
2025
Q3 		$1.04M Sell
15,600
-3,400
-18% -$193K 0.01% 588
2025
Q2 		$1.05M Buy
19,000
+1,400
+8% +$67.2K 0.01% 561
2025
Q1 		$851K Buy
+17,600
New +$737K 0.01% 598

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virginia Retirement Systems's PTGX Position: Q4 2025 in Review

Virginia Retirement Systems increased its Protagonist Therapeutics (PTGX) stake by 63% in Q4 2025, buying an estimated $802K and bringing the position to 25,400 shares worth $2.22M. The position accounts for 0.01% of the portfolio, ranked #400.

Virginia Retirement Systems first reported a position in PTGX in Q1 2025 and has held it in 4 quarters since. 313 funds tracked by Wall St. Rank hold PTGX as of Q4 2025.

  • Virginia Retirement Systems held 25,400 shares of Protagonist Therapeutics worth $2.22M as of Q4 2025.
  • Virginia Retirement Systems bought 9,800 Protagonist Therapeutics shares in Q4 2025, an estimated $802K.
  • Protagonist Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #400 holding.
  • Virginia Retirement Systems first reported a position in Protagonist Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 313 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.